Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections-Reference-Cited by-同舟云学术

Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections

Published:2021-10 Issue:10 Volume:21 Page:e810-e816
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Yasuda Hajime,Mori Yosuke,Chiba Asako,Bai Jie,Murayama Goh,Matsushita Yasushi,Miyake Sachiko,Komatsu Norio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma;Yasuda;Clin Lymphoma Myeloma Leuk,2020

2. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals;Grifoni;Cell,2020

3. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans;Mateus;Science,2020

4. Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature;Tepasse;Br J Haematol,2020

5. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma;Karataş;Transfus Apher Sci,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of the induction of humoral and cellular immunity by third vaccination for SARS-CoV-2;Journal of Infection and Chemotherapy;2024-10

2. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

3. Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies;Journal of Microbiology, Immunology and Infection;2024-06

4. Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases;Frontiers in Immunology;2024-01-25

5. Impact of T-Cell Engagers on COVID-19–Related Mortality in B-Cell Lymphoma Patients Receiving B-Cell Depleting Therapy;Cancer Research and Treatment;2024-01-15